Skip to content
Parakho

Bilcare Ltd-$

NSE BIBSE 526853

Q1 FY27, unaudited

Revenue
₹225.86 Cr
Profit after tax
₹14.97 Cr

As filed with the exchange, consolidated basis.

Statement of profit and loss

Figures in ₹ crore, reproduced from the results data files the company filed with BSE under Regulation 33 of the SEBI (LODR) Regulations. Nothing is restated, adjusted or estimated.

Statement of profit and loss, consolidated basis
₹ croreQ1 FY27vs a year agoFY26
Revenue from operations225.86+21.20%733.54
Other income1.75−71.22%30.00
Total income227.61+18.28%763.54
Employee benefit expense19.77−1.25%79.96
Finance costs18.08−2.53%72.34
Depreciation & amortisation4.11−64.45%19.75
Total expenses211.03+2.74%781.20
Profit before tax14.84+214.51%-21.46
Tax expense-0.13+95.94%-4.17
Profit after tax14.97+253.38%-17.29
Total comprehensive income13.86+244.68%-13.77
Earnings per share
Earnings per share, basic₹5.39₹0.73
Earnings per share, diluted₹5.39₹0.73

Q1 FY27 — unaudited, from the company’s filing with BSE. Source

Q1 FY26, the year-ago base — unaudited, from the company’s filing with BSE. Source

FY26 — from the company’s filing with BSE. Source

Q1 FY27 results for every company Parakho holds

Earnings call

Bilcare Ltd-$ has not filed a concall transcript in the last 4 quarters.

Filings

12 shown · 36 published by the exchange

BSE corporate announcements, classified by Parakho. The exchange’s own category is kept alongside our classification so a reclassification never rewrites history.

Industry

Healthcare › Healthcare Research, Analytics & Technology

Classification as published by BSE.

Companies also in Healthcare Research, Analytics & Technology, in alphabetical order

All 11 companies in Healthcare Research, Analytics & Technology

Page generated from filings held to 29 Sept 2026.